- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Schering’s imaging sales fall
Revenues in Schering’s diagnostics business unit fell 6% in 1998, the German contrast agent developer reported last month. The Berlin-based company attributed the fall primarily to exchange-rate effects, while falling contrast media prices also had
Revenues in Scherings diagnostics business unit fell 6% in 1998, the German contrast agent developer reported last month. The Berlin-based company attributed the fall primarily to exchange-rate effects, while falling contrast media prices also had an impact. Diagnostics sales fell particularly hard in the fourth quarter, the company said.
For the year (end-December), Schering posted imaging sales of DM 1.48 billion ($837.5 million), compared with DM 1.58 billion ($892.4 million) in 1997. Of total sales last year, x-ray contrast media accounted for DM 1.08 billion ($613.4 million), while MRI contrast sales totaled DM 388 million ($219.6 million). For the entire company, Schering reported that sales climbed 3% before exchange-rate adjustments to DM 6.42 billion ($3.64 billion), and the company reported 7% growth in net income, to DM 478 million ($270.5 million).
MRI-Based Deep Learning Algorithm Shows Comparable Detection of csPCa to Radiologists
May 8th 2024In a study involving over 1,000 visible prostate lesions on biparametric MRI, a deep learning algorithm detected 96 percent of clinically significant prostate cancer (csPCa) in comparison to a 98 percent detection rate for an expert genitourinary radiologist.
FDA Clears AI-Powered Qualitative Perfusion Mapping for Cone-Beam CT
May 6th 2024Reportedly validated in more than 10 clinical trials, the AngioFlow perfusion imaging software enables timely identification of brain regions with cerebral blood flow reduction and those with significant hypoperfusion.
